Jesus D. Anampa Mesias
<p><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;">Dr. Jesus Anampa is an Associate Professor of Medicine in the Department of Medical Oncology at Albert Einstein College of Medicine/ Montefiore Medical Center. Dr. Anampa is the Clinical Research Leader for Breast Oncology at Montefiore Medical Center and The Phase I Liaison for Breast Oncology.</span></p>
<p><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;">A native of Peru, Dr. Anampa finished medical school at Universidad Peruana Cayetano Heredia in Lima, Peru, and successfully finished Internal Medicine Residency at Rochester General Hospital in Rochester, NY. Dr. Anampa initially joined Albert Einstein College of Medicine/Montefiore Medical Center to complete his fellowship in hematology/oncology and then joined our medical oncology faculty team at AECOM/MMC. In 2018, he obtained a Master’s of Science degree “with distinction” in clinical research from Albert Einstein College of Medicine. Dr. Anampa is a practicing physician who specializes in breast medical oncology and clinical & translational cancer research. </span></p>
<p><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;"> </span></p>
<p><strong><u><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;">Tumor MicroEnvironment of Metastasis</span></u></strong><u></u></p>
<p><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;">Dr. Anampa is currently working with the tumor microenvironment (TME) program at Albert Einstein College of Medicine, which is a nationwide well-recognized program, lead by Dr. John Condeelis, evaluating new mechanisms of cancer intravasation and dissemination. Dr. Anampa plays an important role in translating bench-to-bedside and bedside-to-bench research in our TME program, and currently, he is working on the Tumor microenvironment of metastasis (TMEM) and its significance as a biomarker in breast cancer. Dr. Anampa is the principal investigator of a novel phase I trial targeting the tumor microenvironment to prevent metastasis. In addition, Dr. Anampa is leading a clinical trial to validate a novel imaging technique to identify metastasis doorways (TMEM) in vivo using MRI in patients with breast cancer.</span></p>
<p><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;"><a href="https://clinicaltrials.gov/ct2/show/NCT03694756">https://clinicaltrials…;
<p><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;"><a href="https://clinicaltrials.gov/ct2/show/NCT02824575">https://clinicaltrials…;
<p><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;"> </span></p>
<p><strong><u><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;">Breast Cancer and Obesity</span></u></strong><u></u></p>
<p><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;">Dr. Anampa is working with the diabetes center at Albert Einstein to identify pathways associated with obesity and breast cancer. Preclinical studies at our institution have demonstrated that the CDK4/6-Rb pathway is affected in diet-induced obesity in mouse models. Dr. Anampa is leading a clinical trial that assesses the effect of CDK 4/6 inhibitors on body composition in patients with metastatic breast cancer.</span></p>
<p><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;"><a href="https://clinicaltrials.gov/ct2/show/NCT03697577">https://clinicaltrials…;
<p><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;"> </span></p>
<p><strong><u><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;">Clinical/Translational Research Leadership</span></u></strong><u></u></p>
<p><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;">Dr. Anampa is The Clinical Research Leader for Breast Oncology at Montefiore Medical Center/AECOM and he serves as local principal investigator for several Phase I, II, and III trials. In addition, Dr. Anampa is also a member of the Protocol Review and monitoring committee at Montefiore Medical Center/AECOM.</span></p>
<p><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;">Dr. Anampa serves as the Montefiore Principal Investigator for the Translational Breast Cancer Research symposium (TBCRC) and the (I-Spy2)</span></p>
<p><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;">Dr. Anampa is a native Spanish-speaker and has an innate passion for breast cancer research, with an ultimate goal to expand breast cancer therapeutic options and improve breast cancer outcomes. Dr. Anampa is also interested in breast cancer research and is always eager to participate in community activities related to breast cancer.</span></p>
<p> </p>
<p><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;">During his free time, Dr. Anampa enjoys mountain biking and soccer.</span></p>
<p>Dr. Anampa is a breast medical oncologist and a member of the Tumor Microenvironment and Metastasis (TMEM) research program at Albert Einstein College of Medicine, which focuses on targeting the tumor microenvironment as a mechanism to prevent the spread of breast cancer.
He is fluent in Spanish and enjoys participating in bilingual community activities about cancer prevention and treatment in the Bronx.</p>
Breast cancer, medical oncology, clinical trials
Tumor micro-environment of metastasis and breast cancer; breast cancer immunology, new mechanisms of metastasis, cancer among minorities, breast cancer risk and outcomes among women with HIV
<p>Jesus Anampa Mesias, MD is a medical oncologist at Montefiore Einstein Comprehensive Cancer Center and a member of its Cancer Therapeutics Research Program focused on identifying new treatment targets and novel cancer therapeutics. He is fluent in Spanish and enjoys participating in bilingual community activities about cancer prevention and treatment in our community.</p><p>Dr. Anampa Mesias received his medical degree from the Universidad Peruana Cayetano Heredia in Lima, Peru, completed his residency in internal medicine at Rochester General Hospital in Rochester, NY, and completed a medical oncology/clinical hematology fellowship at Montefiore Medical Center. He remained at Albert Einstein as a research fellow before joining the medical oncology team at Montefiore.</p><p> </p>